CHR-DB-B Fundamental Analysis - CHORUS AVIATION INC

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to CHR-DB-B. CHR-DB-B was compared to 8 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR-DB-B get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, CHR-DB-B is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CHR-DB-B was profitable.

CHR-DB-B had a positive operating cash flow in the past year.

In multiple years CHR-DB-B reported negative net income over the last 5 years.

CHR-DB-B had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

CHR-DB-B has a worse Return On Assets (-17.42%) than 75.00% of its industry peers.

CHR-DB-B's Return On Equity of -47.80% is on the low side compared to the rest of the industry. CHR-DB-B is outperformed by 62.50% of its industry peers.

CHR-DB-B's Return On Invested Capital of 6.29% is amongst the best of the industry. CHR-DB-B outperforms 87.50% of its industry peers.

Measured over the past 3 years, the Average Return On Invested Capital for CHR-DB-B is in line with the industry average of 5.84%.

The last Return On Invested Capital (6.29%) for CHR-DB-B is above the 3 year average (5.30%), which is a sign of increasing profitability.

		Industry Rank	Sector Rank
ROA	-17.42%
ROE	-47.8%
ROIC	6.29%

ROA(3y)-4.73%

ROA(5y)-2.72%

ROE(3y)-14.73%

ROE(5y)-8.13%

ROIC(3y)5.3%

ROIC(5y)4.78%

1.3 Margins

The Operating Margin of CHR-DB-B (6.77%) is comparable to the rest of the industry.

CHR-DB-B's Operating Margin has declined in the last couple of years.

CHR-DB-B's Gross Margin of 65.04% is amongst the best of the industry. CHR-DB-B outperforms 87.50% of its industry peers.

CHR-DB-B's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	6.77%
PM (TTM)	N/A
GM	65.04%

OM growth 3Y-18.7%

OM growth 5Y-14.78%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-5.38%

GM growth 5Y-2.24%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CHR-DB-B has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

Compared to 1 year ago, CHR-DB-B has less shares outstanding

CHR-DB-B has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, CHR-DB-B has an improved debt to assets ratio.

2.2 Solvency

CHR-DB-B has an Altman-Z score of 2.24. This is not the best score and indicates that CHR-DB-B is in the grey zone with still only limited risk for bankruptcy at the moment.

The Altman-Z score of CHR-DB-B (2.24) is better than 100.00% of its industry peers.

The Debt to FCF ratio of CHR-DB-B is 3.86, which is a good value as it means it would take CHR-DB-B, 3.86 years of fcf income to pay off all of its debts.

CHR-DB-B's Debt to FCF ratio of 3.86 is amongst the best of the industry. CHR-DB-B outperforms 87.50% of its industry peers.

CHR-DB-B has a Debt/Equity ratio of 0.68. This is a neutral value indicating CHR-DB-B is somewhat dependend on debt financing.

With a decent Debt to Equity ratio value of 0.68, CHR-DB-B is doing good in the industry, outperforming 75.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.68
Debt/FCF	3.86
Altman-Z	2.24

ROIC/WACC0.75

WACC8.37%

2.3 Liquidity

CHR-DB-B has a Current Ratio of 1.22. This is a normal value and indicates that CHR-DB-B is financially healthy and should not expect problems in meeting its short term obligations.

With a Current ratio value of 1.22, CHR-DB-B perfoms like the industry average, outperforming 50.00% of the companies in the same industry.

CHR-DB-B has a Quick Ratio of 1.22. This is a bad value and indicates that CHR-DB-B is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Quick ratio value of 0.71, CHR-DB-B is not doing good in the industry: 62.50% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	1.22
Quick Ratio	0.71

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CHR-DB-B shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.14%.

CHR-DB-B shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -19.03% yearly.

Looking at the last year, CHR-DB-B shows a very negative growth in Revenue. The Revenue has decreased by -14.15% in the last year.

CHR-DB-B shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.56% yearly.

EPS 1Y (TTM)-5.14%

EPS 3Y-16.46%

EPS 5Y-19.03%

EPS Q2Q%35.71%

Revenue 1Y (TTM)-14.15%

Revenue growth 3Y11.15%

Revenue growth 5Y0.56%

Sales Q2Q%-18.31%

3.2 Future

The Earnings Per Share is expected to grow by 8.82% on average over the next years. This is quite good.

Based on estimates for the next years, CHR-DB-B will show a small growth in Revenue. The Revenue will grow by 0.78% on average per year.

EPS Next Y62.27%

EPS Next 2Y16.29%

EPS Next 3Y8.82%

EPS Next 5YN/A

Revenue Next Year-2.29%

Revenue Next 2Y-2.03%

Revenue Next 3Y0.78%

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 60.31, which means the current valuation is very expensive for CHR-DB-B.

CHR-DB-B's Price/Earnings ratio is a bit more expensive when compared to the industry. CHR-DB-B is more expensive than 62.50% of the companies in the same industry.

When comparing the Price/Earnings ratio of CHR-DB-B to the average of the S&P500 Index (26.57), we can say CHR-DB-B is valued expensively.

CHR-DB-B is valuated quite expensively with a Price/Forward Earnings ratio of 49.03.

Compared to the rest of the industry, the Price/Forward Earnings ratio of CHR-DB-B indicates a slightly more expensive valuation: CHR-DB-B is more expensive than 62.50% of the companies listed in the same industry.

CHR-DB-B is valuated expensively when we compare the Price/Forward Earnings ratio to 22.41, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	60.31
Fwd PE	49.03

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHR-DB-B is valued a bit more expensive than the industry average as 75.00% of the companies are valued more cheaply.

Based on the Price/Free Cash Flow ratio, CHR-DB-B is valued a bit cheaper than 62.50% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	24.42
EV/EBITDA	16.31

4.3 Compensation for Growth

CHR-DB-B's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

PEG (NY)0.97

PEG (5Y)N/A

EPS Next 2Y16.29%

EPS Next 3Y8.82%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CHR-DB-B!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CHORUS AVIATION INC

TSX:CHR-DB-B (6/11/2025, 7:00:00 PM)

100.12

-0.04 (-0.04%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupTransportation

GICS IndustryPassenger Airlines

Earnings (Last)05-06 2025-05-06/amc

Earnings (Next)08-12 2025-08-12/amc

Inst Owners2.5%

Inst Owner ChangeN/A

Ins Owners1.32%

Ins Owner ChangeN/A

Market Cap2.65B

Analysts78.18

Price Target133.9 (33.74%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0.98

Dividend Growth(5Y)21.58%

DP-7.29%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)14.69%

Min EPS beat(2)3.87%

Max EPS beat(2)25.51%

EPS beat(4)3

Avg EPS beat(4)39.29%

Min EPS beat(4)-80.2%

Max EPS beat(4)207.96%

EPS beat(8)4

Avg EPS beat(8)7.83%

EPS beat(12)5

Avg EPS beat(12)1.78%

EPS beat(16)7

Avg EPS beat(16)0.15%

Revenue beat(2)0

Avg Revenue beat(2)-3.86%

Min Revenue beat(2)-3.95%

Max Revenue beat(2)-3.78%

Revenue beat(4)0

Avg Revenue beat(4)-6.49%

Min Revenue beat(4)-10.27%

Max Revenue beat(4)-3.78%

Revenue beat(8)3

Avg Revenue beat(8)-1.85%

Revenue beat(12)5

Avg Revenue beat(12)-1.08%

Revenue beat(16)9

Avg Revenue beat(16)6.44%

PT rev (1m)0%

PT rev (3m)-3.99%

EPS NQ rev (1m)4.53%

EPS NQ rev (3m)718.22%

EPS NY rev (1m)6.33%

EPS NY rev (3m)13.9%

Revenue NQ rev (1m)0.17%

Revenue NQ rev (3m)0.14%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	60.31
Fwd PE	49.03
P/S	1.9
P/FCF	24.42
P/OCF	17.73
P/B	5.13
P/tB	5.22
EV/EBITDA	16.31

EPS(TTM)1.66

EY1.66%

EPS(NY)2.04

Fwd EY2.04%

FCF(TTM)4.1

FCFY4.1%

OCF(TTM)5.65

OCFY5.64%

SpS52.7

BVpS19.51

TBVpS19.18

PEG (NY)0.97

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-17.42%
ROE	-47.8%
ROCE	8.48%
ROIC	6.29%
ROICexc	6.74%
ROICexgc	6.8%
OM	6.77%
PM (TTM)	N/A
GM	65.04%
FCFM	7.78%

ROA(3y)-4.73%

ROA(5y)-2.72%

ROE(3y)-14.73%

ROE(5y)-8.13%

ROIC(3y)5.3%

ROIC(5y)4.78%

ROICexc(3y)5.99%

ROICexc(5y)5.28%

ROICexgc(3y)6.05%

ROICexgc(5y)5.32%

ROCE(3y)7.14%

ROCE(5y)6.44%

ROICexcg growth 3Y33.52%

ROICexcg growth 5Y7.31%

ROICexc growth 3Y33.18%

ROICexc growth 5Y7.15%

OM growth 3Y-18.7%

OM growth 5Y-14.78%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-5.38%

GM growth 5Y-2.24%

F-Score6

Asset Turnover0.98

Health

		Industry Rank	Sector Rank
Debt/Equity	0.68
Debt/FCF	3.86
Debt/EBITDA	1.9
Cap/Depr	45.9%
Cap/Sales	2.93%
Interest Coverage	1.46
Cash Conversion	81.41%
Profit Quality	N/A
Current Ratio	1.22
Quick Ratio	0.71
Altman-Z	2.24

F-Score6

WACC8.37%

ROIC/WACC0.75

Cap/Depr(3y)31.44%

Cap/Depr(5y)62.49%

Cap/Sales(3y)3.58%

Cap/Sales(5y)12.17%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-5.14%

EPS 3Y-16.46%

EPS 5Y-19.03%

EPS Q2Q%35.71%

EPS Next Y62.27%

EPS Next 2Y16.29%

EPS Next 3Y8.82%

EPS Next 5YN/A

Revenue 1Y (TTM)-14.15%

Revenue growth 3Y11.15%

Revenue growth 5Y0.56%

Sales Q2Q%-18.31%

Revenue Next Year-2.29%

Revenue Next 2Y-2.03%

Revenue Next 3Y0.78%

Revenue Next 5YN/A

EBIT growth 1Y-59.15%

EBIT growth 3Y-9.64%

EBIT growth 5Y-14.31%

EBIT Next Year88.24%

EBIT Next 3Y15.21%

EBIT Next 5YN/A

FCF growth 1Y-55.84%

FCF growth 3Y24.37%

FCF growth 5YN/A

OCF growth 1Y-51.04%

OCF growth 3Y12.73%

OCF growth 5Y0.25%

CHORUS AVIATION INC (CHR-DB-B.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens